Non-Independent Chair of the Board, President & Chief Executive Officer, West Pharmaceutical
Search every verified Eric Green interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Eric Green, President and Chief Executive Officer of West Pharmaceutical Services, discussed the company's financial performance and strategic priorities during recent earnings calls. In the fourth quarter 2024 call, he identified biologics, GLP-1s, and Annex 1 compliance as key growth areas, noting a multi-year contract with a major manufacturer for GLP-1 primary packaging elastomer needs. He also stated the company had decided not to participate in certain continuous glucose monitoring projects because financial thresholds could not be achieved, with one customer exiting and another intending to exit in mid-2026. In the second quarter 2026 call, Green reported raised full-year guidance, citing 10-11% organic revenue growth and adjusted EPS of $8.85 to $9.50, with the proprietary product segment growing 16% organically, led by biologics. Green has also spoken publicly about the company's broader mission and history. At the 2023 Baron Investment Conference, he described West's role in primary containment and delivery of injectable medicines, stating that seven out of ten injections globally use West products. He emphasized that the company's core focus on elastomeric components and pharmaceutical drug material has remained consistent over a century, and he highlighted the firm's investment in capacity during the COVID-19 pandemic as fungible for other molecules, particularly in the biologics space. In 2024, he received a Distinguished Alumni Award from Olin Business School at Washington University, where he credited his business education, particularly data-driven decision-making, as influential to his leadership approach.
For more than 34 years, Olin Business School has recognized and presented Distinguished Alumni Awards honoring alumni who have attained distinction in their careers. Those honored share the characteristics of leadership: progressive thinking, high standards, uncompromising integrity, commitment, courage and confidence. Their careers serve as models for all Washington University students and alumni. Olin Business School proudly honors three Olin alumni this year with the Distinguished Alumni Award on April 4, 2024: Andrea Adegas Faccio, EMBA 2017 | President & Chief Growth Officer, Nestlé Puri…
West Pharmaceutical CEO Eric Green speaks at the 30th Annual Baron Investment Conference. ▬ Contents of this video ▬▬▬▬▬▬▬▬▬▬ 0:00 – Introduction to West Pharmaceuticals 1:33 – 100 Years of Growth 7:21 – Products and New Innovations for Growth 18:27 – Responding to the COVID-19 Pandemic 23:22 – Capital Expenditures and Business Performance 26:37 – ESG, Philanthropy, and Community Involvement 29:31 – Preventing Drug Contamination 31:42 – Delivering Larger Molecule Drugs 34:15 – Drug Delivery Device Development 36:57 – Minimizing Manufacturing Defects 39:05 – Quality Control Challenges ------…
Sign in to search the full transcript archive, filter by topic, and access every quote from Eric Green.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →
Pro unlocks every transcript in full, plus unlimited search across every executive and company we cover.
50% off appliedPulling data at scale? The Data API gives you 30,000 transcripts a month over REST, MCP and JSON.
Compare all plans